Transparency Market Research Report Added “Platelet Rich Plasma Market - Global Industry Analysis, Size, Share, Growth, Trends & Forecast 2014 - 2020” to its database.

Albany, NY -- (SBWire) -- 09/26/2016 --Platelet rich plasma (PRP) is a blood plasma derived product, which typically contains an elevated level of platelets and growth factors (at least four to eight times) than normal blood concentration. Increasing number of orthopedic surgeries and sports injuries, rising number of cosmetic surgeries, approval of new devices and discovery of new application areas and growing awareness amongst the global population are the prime factors driving the growth of global PRP market. According to the statistics provided by the International Society of Plastic and Aesthetic Surgeons (ISAPS), 11 million non-invasive cosmetic procedures were performed worldwide in 2013, including approximately 3.0 million dermal filler procedures. This extensive number of cosmetic surgeries performed is considered as one of the most prominent factor propelling the growth of the global PRP market during the forecast period from 2014 to 2020. Furthermore, increasing application areas such as erectile dysfunction and vampire facelift also support the market growth in the near future. However, high cost of the devices and therapy and threat of therapy failure are some of the factors restricting the market growth to some extent.

Request free Sample pages of premium Research Report: http://bit.ly/2cFDE1P

Platelet rich plasma is a blood plasma product wherein a blood sample is spun to increase the concentration of platelets to four to eight times the normal blood platelet concentration. Platelet rich plasma is also referred to as platelet rich gel, platelet enriched gel, and platelet enriched plasma. Platelet rich plasma is an effective treatment to treat numerous diseases such as sports injuries, cardiothoracic diseases, neurological diseases, and orthopedic diseases. Also, PRP therapy finds applications in the cosmetic industry.

The global platelet rich plasma market is segmented on the basis of geography, application, origin, and type. Based on type, the global platelet rich plasma market is classified into pure platelet rich plasma (pure-PRP), pure PRF/leukocyte-rich PRF, and leukocyte-rich PRP. In 2013, the global platelet rich plasma market was dominated by the pure platelet rich plasma segment due to the extensive use of P-PRP for various orthopedic diseases.

Based on origin, the global platelet rich plasma market is classified into homologous, autologous, and allogenic PRP. In 2013, the global platelet rich plasma market was led by the autologous PRP segment due to its cost effectiveness, lowest threat of disease, and ease of production.

PRP finds applications in neurosurgery, orthopedic surgery, cosmetic surgery, general surgery, and others. In 2013, orthopedic surgery was the biggest application segment in the global platelet rich plasma market.

By geography, the global platelet rich plasma market is divided into North America, Asia Pacific, Europe, and Rest of the World. Some of the prominent players operating in the global platelet rich plasma market are AdiStem Ltd., Arthrex, Inc., Cesca Therapeutics, Inc., Dr. PRP America LLC., Exactech, Inc., Nuo Therapeutics, Inc., Arteriocyte Medical Systems, Inc., Biomet, Inc., DePuy Synthes, Inc., EmCyte Corporation, Harvest Technologies Corp., and Stryker Corporation.

The global platelet-rich plasma market is anticipated to expand at a CAGR of 11.9% during the period between 2014 and 2020. The market stood at a valuation of US$0.16 bn in 2013 and is projected to be worth US$0.35 bn by 2020.

Technological advancements, regulatory approvals for new devices, the increasing occurrence of orthopedic diseases, the rising prevalence of sports injuries, and the growing awareness about PRP devices and products in emerging economies are predicted to propel the global platelet rich plasma market in the years to come. However, factors such as the high cost of PRP devices and the threat of the therapy failing are predicted to hamper the growth of the global platelet rich plasma market in the next few years. Also, the possibility of the transfer of a disease in the case of homologous and allogenic PRP is expected to restrict the growth of the global platelet rich plasma market.

About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/